Form 4 for AVTX Avalo Therapeutics, Inc.
Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-24 · accession 0001929354-23-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-05-24 | 2023-05-24 | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $2.98 | +9,000 | 1.38M | +0.7% | +$26.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-24 | P | A | 3,481 | $3.01 | 1,377,181 | I See Footnote (1) | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.0 to $3.01, inclusive. (F1) Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh. |
| 2 | Common | Common Stock | 2023-05-24 | P | A | 5,519 | $2.96 | 1,382,700 | I See Footnote (1) | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.92 to $3.03, inclusive. (F1) Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh. |